Table 1.
Characteristic | N (%) | |
---|---|---|
Gender | Male | 50 (54.5) |
Female | 41 (45.5) | |
Age | Median: 66 (IQR 60–71 years) | |
Histology | Clear cell | 88 (97) |
other | 3 (3) | |
Grade | Low (G1–2) | 28 (30) |
High (G3–4) | 63 (70) | |
T | 3a | 88 (97) |
3b | 1 (1) | |
3c | - | |
4 | 2 (2) | |
N | 0 | 78 (86) |
1 | 13 (14) | |
M | 0 | 67 (74) |
1 | 24 (26) | |
R | 0 | 70 (77) |
1–2 | 21 (23) | |
Tumor necrosis | Present | 41 (45.5) |
absent | 50 (54.5) | |
Mayo stage | Low (0–1) | 85 (93) |
High (≥2) | 6 (7) | |
LOH | Short (≤9 days) | 61 (67) |
Long | 29 (33) | |
Clavien-Dindo | Low (0–1) | 79 (87) |
High ≥2 | 12 (13) | |
Death during follow-up | No | 58 (64) |
Yes | 33 (36) | |
Preoperative values | Lymphocytes | median 1.55 IQR—1.18–2.12 |
Monocytes | median 0.82 IQR—0.6–1.04 |
|
Neutrophils | median 4.91 IQR—3.8–6.26 |
|
Platelets | median 262.5 IQR—220–334 |
|
LMR | median—1.96 IQR—1.41–3.05 |
|
NLR | median—3.18 IQR—2.04–4.79 |
|
PLR | median—166 IQR—119–234 |